Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease

被引：0
|
作者：
Gkiouras, Konstantinos [1 ]
Grammatikopoulou, Maria G. [1 ,2 ]
Simopoulou, Theodora [1 ]
Daniil, Zoe [3 ]
Bogdanos, Dimitrios P. [1 ]
机构：
[1] Univ Thessaly, Dept Rheumatol & Clin Immunol, Fac Med, Sch Hlth Sci, Larisa, Greece
[2] Int Hellen Univ, Dept Nutr Sci & Dietet, Fac Hlth Sci, Alexander Campus, Thessaloniki, Greece
[3] Univ Thessaly, Dept Resp, Med Dept, Fac Med, Larisa, Greece
来源：
CLINICAL RHEUMATOLOGY | 2021年 / 40卷 / 08期
关键词：
METAANALYSES;
D O I：
10.1007/s10067-021-05845-x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3379 / 3380
页数：2
相关论文
共 50 条
  • [21] MYCOPHENOLATE MOFETIL VERSUS ORAL CYCLOPHOSPHAMIDE IN SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE: SCLERODERMA LUNG STUDY II
    Khanna, D.
    Roth, M.
    Clements, P.
    Furst, D.
    Tseng, C. -H.
    Elashoff, R.
    Volkmann, E.
    Kafaja, S.
    Goldin, J.
    Tashkin, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 531 - 531
  • [22] Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review
    Parikh, Aneri
    Francis, Aida J.
    Sreenivasan, Chithra
    Pandey, Manorama
    AlQassab, Osamah
    Kanthajan, Tatchaya
    AlEdani, Esraa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [23] Detection and classification of systemic sclerosis-related interstitial lung disease: a review
    DeMizio, Daniel J.
    Bernstein, Elana J.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (06) : 553 - 560
  • [24] Effects of Mycophenolate Mofetil on Pulmonary Lung Function in Interstitial Lung Disease of Systemic Sclerosis.
    Pham, Michael
    Griffing, W. Leroy
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S742 - S742
  • [25] Update on morbidity and mortality in systemic sclerosis-related interstitial lung disease
    Volkmann, Elizabeth R.
    Fischer, Aryeh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2021, 6 (01) : 11 - 20
  • [26] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Mango, Robert L.
    Matteson, Eric L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Makol, Ashima
    LUNG, 2018, 196 (04) : 409 - 416
  • [27] Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension
    Vakhshoorzadeh, Jasmine
    Lui, Justin K.
    Sangani, Ruchika A.
    Trojanowski, Marcin A.
    Bujor, Andreea M.
    LaValley, Michael P.
    Klings, Elizabeth S.
    RESPIRATORY MEDICINE, 2023, 216
  • [28] Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
    Lee, Shih-Ching
    Huang, Chen-Hao
    Oyang, Yen-Jen
    Huang, Hsuan-Cheng
    Juan, Hsueh-Fen
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [29] Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
    Robert L. Mango
    Eric L. Matteson
    Cynthia S. Crowson
    Jay H. Ryu
    Ashima Makol
    Lung, 2018, 196 : 409 - 416
  • [30] Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis
    Ueda, Takahiro
    Sakagami, Takuro
    Kikuchi, Toshiaki
    Takada, Toshinori
    RESPIRATORY INVESTIGATION, 2018, 56 (01) : 14 - 20
12345